<unk> , sold under the brand name Longidaze, is a conjugate of proteolytic enzyme hyaluronidase with high- molecular weight copolymer that forms a component of combination therapy regimens for treatment and prevention of diseases associated with connective tissue hyperplasia. The most frequently observed adverse reactions seen with<unk>  include pain at site of injection and injection site reaction n such as skin redness, itching and oedema. All local reactions resolve themselves in 48 – 72 hours.
Bovhyaluronidase azoximer
Mucrocetin
Alglucosidase alfa
Vestronidase alfa
Avalglucosidase alfa
Acemannan
Gadobenic acid
Elapegademase